Manoranjan M. Sharma

发表

Effect of pioglitazone on metabolic features in endotoxemia model in obese diabetic db/db mice

Mukul R Jain, A. Chatterjee, Manoranjan M. Sharma, 2017, Journal of diabetes.

Involvement of adipokines in rimonabant‐mediated insulin sensitivity in ob/ob mice

Satinder K. Singh, R. Balaraman, Mukul R Jain, 2009, The Journal of pharmacy and pharmacology.

Dialysis dysequilibrium syndrome in a case of hemorrhagic stroke with chronic kidney disease: Bermuda triangle of neurocritical care

V. Tomar, M. Tripathi, H. Deora, 2020 .

Subtherapeutic Dose of Pioglitazone Reduces Expression of Inflammatory Adipokines in db/db Mice

Satinder K. Singh, R. Balaraman, Mukul R Jain, 2009, Pharmacology.

Retinol‐binding protein 4 : a possible role in cardiovascular complications

R. Balaraman, Mukul R Jain, Aviseka Acharya, 2011, British journal of pharmacology.

Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans?

Mukul R Jain, Aviseka Acharya, A. Chatterjee, 2013, European journal of pharmacology.

Investigation into the Role of PI3K and JAK3 Kinase Inhibitors in Murine Models of Asthma

Mukul R Jain, V. Addepalli, Manoranjan M. Sharma, 2017, Front. Pharmacol..

Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT-1 activation.

Mukul R Jain, Hiren M Patel, D. Pandey, 2014, Cytokine.

Selective inhibition of tumor necrosis factor-α converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis.

Mukul R Jain, Hiren M Patel, D. Pandey, 2013, International immunopharmacology.

Ameliorative potential of aliskiren in experimental colitis in mice.

Mukul R Jain, Hiren M Patel, Manoranjan M. Sharma, 2014, European journal of pharmacology.

Anti-cytokine and anti-hyperalgesic effects of aliskiren in experimental models of inflammation

Manoranjan M. Sharma, Bhavin M. Sonara, Kanaiyalal D. Prajapati, 2014 .

ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer

D. Bandyopadhyay, Rajiv Sharma, N. Srinivas, 2020, Pharmacology research & perspectives.

Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: Possible role of tissue inhibitor of metalloproteinase-3

H. Soni, Mukul R Jain, A. Chatterjee, 2015, Indian journal of pharmacology.

Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis

Mukul R Jain, G. Shah, A. Chatterjee, 2014, Immunopharmacology and immunotoxicology.

Impact of collagen-induced arthritis on the pharmacokinetic disposition of voriconazole, a widely used antifungal agent: in vitro and in vivo investigations in DBA/1J mice

N. Srinivas, Shekhar Kadam, P. Giri, 2018, Xenobiotica; the fate of foreign compounds in biological systems.

Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor.

D. Bandyopadhyay, Mukul R Jain, P. Giri, 2022, Bioorganic & Medicinal Chemistry Letters.

Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitors.

D. Bandyopadhyay, Mukul R Jain, P. Jadav, 2022, Bioorganic chemistry.